Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    These changes appear to be metadata-level updates, including a new revision tag (v3.3.2) and revised timestamps, with no impact on core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-12-01T17:50:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1 instead of Revision: v3.2.0. This is a minor metadata update and does not alter study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-24T14:50:29.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study site entries for Tainan were updated from 'Tainan City, Taiwan, 70403' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 70403' and 'Tainan, Taiwan, 736'. A government funding status notice was removed.
    Difference
    0.1%
    Check dated 2025-11-17T07:32:42.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    There are no significant changes to core study information (arms, outcomes, eligibility criteria, locations); any observed differences are limited to minor UI/formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:26:03.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:28:28.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Update: revision updated from v3.0.2 to v3.1.0 and addition of a contact/identifier line (1-833-445-3230, GILEAD-0).
    Difference
    0.0%
    Check dated 2025-09-28T03:21:23.000Z thumbnail image

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.